The generic is approved for adults with obesity, or adults who are overweight with at least one weight-related condition such as high blood pressure or type 2 diabetes
"With orforglipron, we're working to transform obesity care by introducing a potential once-daily oral therapy that could support early intervention and long-term disease management, while offering a convenient alternative to injectable treatments," Kenneth Custer, an executive vice president and president of Lilly Cardiometabolic Health, said in a statement
Bring your most recent lab results, including fasting glucose, HbA1c, lipid panel, thyroid function, and liver enzymes
As a result, expanding access to these therapies could have both clinical and economic advantages
RYBELSUS is a glucagonlike peptide1 (GLP1) drug, the same class as Ozempic and Wegovy, but in pill form
Feel like you again